284 related articles for article (PubMed ID: 18171609)
1. The diminishment of experimental autoimmune encephalomyelitis (EAE) by neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH) therapy.
Taylor AW; Kitaichi N
Brain Behav Immun; 2008 Jul; 22(5):639-46. PubMed ID: 18171609
[TBL] [Abstract][Full Text] [Related]
2. In vitro induction of CD25+ CD4+ regulatory T cells by the neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH).
Taylor A; Namba K
Immunol Cell Biol; 2001 Aug; 79(4):358-67. PubMed ID: 11488983
[TBL] [Abstract][Full Text] [Related]
3. Prevention and treatment of experimental autoimmune encephalomyelitis with recombinant adeno-associated virus-mediated alpha-melanocyte-stimulating hormone-transduced PLP139-151-specific T cells.
Han D; Tian Y; Zhang M; Zhou Z; Lu J
Gene Ther; 2007 Mar; 14(5):383-95. PubMed ID: 17066098
[TBL] [Abstract][Full Text] [Related]
4. SVα-MSH, a novel α-melanocyte stimulating hormone analog, ameliorates autoimmune encephalomyelitis through inhibiting autoreactive CD4(+) T cells activation.
Fang J; Han D; Hong J; Zhang H; Ying Y; Tian Y; Zhang L; Lin J
J Neuroimmunol; 2014 Apr; 269(1-2):9-19. PubMed ID: 24518673
[TBL] [Abstract][Full Text] [Related]
5. Induction of regulatory T cells by the immunomodulating cytokines alpha-melanocyte-stimulating hormone and transforming growth factor-beta2.
Namba K; Kitaichi N; Nishida T; Taylor AW
J Leukoc Biol; 2002 Nov; 72(5):946-52. PubMed ID: 12429716
[TBL] [Abstract][Full Text] [Related]
6. Estrogen treatment induces a novel population of regulatory cells, which suppresses experimental autoimmune encephalomyelitis.
Matejuk A; Bakke AC; Hopke C; Dwyer J; Vandenbark AA; Offner H
J Neurosci Res; 2004 Jul; 77(1):119-26. PubMed ID: 15197745
[TBL] [Abstract][Full Text] [Related]
7. IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells.
Zhang X; Koldzic DN; Izikson L; Reddy J; Nazareno RF; Sakaguchi S; Kuchroo VK; Weiner HL
Int Immunol; 2004 Feb; 16(2):249-56. PubMed ID: 14734610
[TBL] [Abstract][Full Text] [Related]
8. Alpha-melanocyte-stimulating hormone suppresses antigen-stimulated T cell production of gamma-interferon.
Taylor AW; Streilein JW; Cousins SW
Neuroimmunomodulation; 1994; 1(3):188-94. PubMed ID: 7489333
[TBL] [Abstract][Full Text] [Related]
9. Decreased severity of experimental autoimmune encephalomyelitis during resveratrol administration is associated with increased IL-17+IL-10+ T cells, CD4(-) IFN-gamma+ cells, and decreased macrophage IL-6 expression.
Imler TJ; Petro TM
Int Immunopharmacol; 2009 Jan; 9(1):134-43. PubMed ID: 19022403
[TBL] [Abstract][Full Text] [Related]
10. Antigen-specific suppression of experimental autoimmune encephalomyelitis by a novel bifunctional peptide inhibitor.
Kobayashi N; Kobayashi H; Gu L; Malefyt T; Siahaan TJ
J Pharmacol Exp Ther; 2007 Aug; 322(2):879-86. PubMed ID: 17522343
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide regulation of immunity. The immunosuppressive activity of alpha-melanocyte-stimulating hormone (alpha-MSH).
Taylor AW; Yee DG; Nishida T; Namba K
Ann N Y Acad Sci; 2000; 917():239-47. PubMed ID: 11268350
[TBL] [Abstract][Full Text] [Related]
12. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
Murphy AC; Lalor SJ; Lynch MA; Mills KH
Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
[TBL] [Abstract][Full Text] [Related]
13. The protective effects of omega-6 fatty acids in experimental autoimmune encephalomyelitis (EAE) in relation to transforming growth factor-beta 1 (TGF-beta1) up-regulation and increased prostaglandin E2 (PGE2) production.
Harbige LS; Layward L; Morris-Downes MM; Dumonde DC; Amor S
Clin Exp Immunol; 2000 Dec; 122(3):445-52. PubMed ID: 11122253
[TBL] [Abstract][Full Text] [Related]
14. Autoantigen-specific immunosuppression with tolerogenic peripheral blood cells prevents relapses in a mouse model of relapsing-remitting multiple sclerosis.
Kleist C; Mohr E; Gaikwad S; Dittmar L; Kuerten S; Platten M; Mier W; Schmitt M; Opelz G; Terness P
J Transl Med; 2016 May; 14(1):99. PubMed ID: 27131971
[TBL] [Abstract][Full Text] [Related]
15. Lack of adiponectin leads to increased lymphocyte activation and increased disease severity in a mouse model of multiple sclerosis.
Piccio L; Cantoni C; Henderson JG; Hawiger D; Ramsbottom M; Mikesell R; Ryu J; Hsieh CS; Cremasco V; Haynes W; Dong LQ; Chan L; Galimberti D; Cross AH
Eur J Immunol; 2013 Aug; 43(8):2089-100. PubMed ID: 23640763
[TBL] [Abstract][Full Text] [Related]
16. Soluble egg antigen from Schistosoma japonicum modulates the progression of chronic progressive experimental autoimmune encephalomyelitis via Th2-shift response.
Zheng X; Hu X; Zhou G; Lu Z; Qiu W; Bao J; Dai Y
J Neuroimmunol; 2008 Feb; 194(1-2):107-14. PubMed ID: 18207251
[TBL] [Abstract][Full Text] [Related]
17. The type IV phosphodiesterase specific inhibitor mesopram inhibits experimental autoimmune encephalomyelitis in rodents.
Dinter H; Tse J; Halks-Miller M; Asarnow D; Onuffer J; Faulds D; Mitrovic B; Kirsch G; Laurent H; Esperling P; Seidelmann D; Ottow E; Schneider H; Tuohy VK; Wachtel H; Perez HD
J Neuroimmunol; 2000 Aug; 108(1-2):136-46. PubMed ID: 10900347
[TBL] [Abstract][Full Text] [Related]
18. Interferon gamma, interleukin 4 and transforming growth factor beta in experimental autoimmune encephalomyelitis in Lewis rats: dynamics of cellular mRNA expression in the central nervous system and lymphoid cells.
Issazadeh S; Mustafa M; Ljungdahl A; Höjeberg B; Dagerlind A; Elde R; Olsson T
J Neurosci Res; 1995 Apr; 40(5):579-90. PubMed ID: 7602612
[TBL] [Abstract][Full Text] [Related]
19. Antigen-specific inhibition of immune interferon production by suppressor cells of autoimmune encephalomyelitis.
McDonald AH; Swanborg RH
J Immunol; 1988 Feb; 140(4):1132-8. PubMed ID: 2963860
[TBL] [Abstract][Full Text] [Related]
20. The mechanism of sesame oil in ameliorating experimental autoimmune encephalomyelitis in C57BL/6 mice.
Ghazavi A; Mosayebi G
Phytother Res; 2012 Jan; 26(1):34-8. PubMed ID: 21538630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
